Detalhe da pesquisa
1.
Efficacy of chemotherapy protocols for hematological malignancies: H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
Exp Hematol
; 101-102: 49-57, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34403757
2.
Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
Ecancermedicalscience
; 15: 1206, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33912231
3.
Risk factors and outcome of COVID-19 in patients with hematological malignancies.
Exp Hematol Oncol
; 9: 21, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32864192